Is tumoral melanosis still a challenge? A case of tumoral melanosis without metastasis

Affiliations

¹ Section of Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy.
² Pathology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
³ Dermatologic Unit, University Hospital of Parma, Parma, Italy.

Case Reports

Alessandra Massa et al. Int J Dermatol. 2023 Dec.

. 2023 Dec;62(12):e618-e620.

doi: 10.1111/ijd.16830. Epub 2023 Sep 6.

¹ Section of Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy.
² Pathology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
³ Dermatologic Unit, University Hospital of Parma, Parma, Italy.

No abstract available

References

1. Arias NM, Peñaranda JMS, Gaspar LS, Mosquera AC, Sánchez-Aguilar D. Tumoral melanosis associated with nivolumab therapy for metastatic melanoma. J Dtsch Dermatol Ges. 2022;20(8):1130-1131.
1. Relvas M, Alves F, Mariano A, Cardoso J, Coutinho I. Tumoral melanosis after immunotherapy with pembrolizumab - a response sign mimicking melanoma. Dermatol Online J. 2020;26(10):13030/qt4xc955rq.
1. Staser K, Chen D, Solus J, Rosman IS, Schaffer A, Cornelius L, et al. Extensive tumoral melanosis associated with ipilimumab-treated melanoma. Br J Dermatol. 2016;175(2):391-393.
1. Jurgens A, Guru S, Guo R, Brewer J, Bridges A, Jakub J, et al. Tumoral melanosis in the setting of targeted immunotherapy for metastatic melanoma-a single institutional experience and literature review. Am J Dermatopathol. 2021;43(1):9-14.
1. Miola AC, Esposito ACC, Stolf HO, Miot HA. Tumoral melanosis without metastasis: a report after three years of follow-up. An Bras Dermatol. 2021;96(6):797-798.